Cargando…

COVID-19 vaccination willingness among people with multiple sclerosis

BACKGROUND: Hesitancy to receive COVID-19 vaccination is a major public health concern. COVID-19 vaccine willingness and the factors contributing to willingness in adults with multiple sclerosis (MS) is unknown. We administered an online survey from 1 December 2020 to 7 January 2021 to adults with M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Xinran M, Hollen, Chris, Yang, Qian, Brumbach, Barbara H, Spain, Rebecca I, Wooliscroft, Lindsey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172949/ https://www.ncbi.nlm.nih.gov/pubmed/34104472 http://dx.doi.org/10.1177/20552173211017159

Ejemplares similares

Enlarged perivascular spaces are not associated with vascular co-morbidities, clinical outcomes, and brain volumes in people with secondary progressive multiple sclerosis
por: Wooliscroft, Lindsey, et al.
Publicado: (2020)

Participant Perspectives on Community Qigong for People with Multiple Sclerosis
por: Buttolph, Lita, et al.
Publicado: (2023)

Oligoclonal Bands in Multiple System Atrophy: Case Report and Proposed Mechanisms of Immunogenicity
por: Neilson, Lee E., et al.
Publicado: (2022)

Oxidative stress in multiple sclerosis—Emerging imaging techniques
por: Hollen, Christopher, et al.
Publicado: (2023)

Protocol for an exploratory, randomised, single-blind clinical trial of aerobic exercise to promote remyelination in multiple sclerosis
por: Wooliscroft, Lindsey, et al.
Publicado: (2023)

Multiple Sclerosis Management During the COVID-19 Pandemic
por: Hollen, Chris, et al.
Publicado: (2022)

Willingness to receive a COVID-19 vaccine in people with multiple sclerosis – UK MS Register survey
por: Huang, Yun, et al.
Publicado: (2021)

Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States
por: Ehde, Dawn M., et al.
Publicado: (2021)

Vaccine hesitancy among people with multiple sclerosis
por: Yap, Siew Mei, et al.
Publicado: (2021)

Recent developments in multiple sclerosis therapeutics
por: Spain, Rebecca I, et al.
Publicado: (2009)

COVID-19 vaccine hesitancy among Italian people with multiple sclerosis
por: Proietti, Francesca, et al.
Publicado: (2022)

Vaccine hesitancy in people with multiple sclerosis
por: Lechner-Scott, Jeannette S, et al.
Publicado: (2022)

COVID-19 Vaccination Willingness Among People Living With HIV in Wuhan, China
por: Wu, Songjie, et al.
Publicado: (2022)

COVID-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients: A Cross Sectional Study in Iran
por: Nabavi, Seyed Massood, et al.
Publicado: (2022)

Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic
por: Heidler, Felicita, et al.
Publicado: (2022)

COVID‐19 Vaccine Response in People with Multiple Sclerosis
por: Tallantyre, Emma C., et al.
Publicado: (2021)

Ready for Vaccination? COVID-19 Vaccination Willingness of Older People in Austria
por: Richter, Lukas, et al.
Publicado: (2022)

Willingness to be vaccinated against COVID-19: An exploratory online survey in a Portuguese cohort of multiple sclerosis patients
por: Serrazina, Filipa, et al.
Publicado: (2021)

COVID-19 vaccines and patients with multiple sclerosis: willingness, unwillingness and hesitancy: a systematic review and meta-analysis
por: Yazdani, Amid, et al.
Publicado: (2022)

COVID-19 vaccination uptake in people with multiple sclerosis compared to the general population
por: Mayer, Dijana, et al.
Publicado: (2023)

Mind-Body Medicine for Multiple Sclerosis: A Systematic Review
por: Senders, Angela, et al.
Publicado: (2012)

Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis
por: Allen-Philbey, K., et al.
Publicado: (2021)

Telehealth in Multiple Sclerosis Clinical Care and Research
por: Xiang, Xinran Maria, et al.
Publicado: (2021)

COVID-19 Vaccination in People with Multiple Sclerosis. the Kuwait Experience
por: Alroughani, Raed, et al.
Publicado: (2022)

Did it hurt? COVID-19 vaccination experience in people with multiple sclerosis
por: Allen-Philbey, K., et al.
Publicado: (2022)

Willingness to Take COVID-19 Vaccine Among People Most at Risk of Exposure in Southern Ethiopia
por: Zewude, Bewunetu, et al.
Publicado: (2021)

COVID-19: The Course, Vaccination and Immune Response in People with Multiple Sclerosis: Systematic Review
por: Bazylewicz, Marcin, et al.
Publicado: (2023)

Fall Prediction Based on Instrumented Measures of Gait and Turning in Daily Life in People with Multiple Sclerosis
por: Arpan, Ishu, et al.
Publicado: (2022)

Vaccine response in people with multiple sclerosis treated with fumarates
por: Tremblay, Matthew A., et al.
Publicado: (2023)

Vaccination frequency in people newly diagnosed with multiple sclerosis
por: Darvishi, Sonia, et al.
Publicado: (2023)

People’s perceptions of, willingness-to-take preventive remedies and their willingness-to-vaccinate during times of heightened health threats
por: Bearth, Angela, et al.
Publicado: (2022)

Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis
por: Shin, Robert K., et al.
Publicado: (2021)

Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis
por: Tallantyre, Emma C, et al.
Publicado: (2022)

COVID-19 vaccination in people with multiple sclerosis, real-life experience
por: Alroughani, Raed, et al.
Publicado: (2022)

COVID-19 Vaccination and Disease Course in People with Multiple Sclerosis in Greece
por: Bakirtzis, Christos, et al.
Publicado: (2023)

Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China
por: Zhou, Hui Jun, et al.
Publicado: (2022)

Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine
por: Moniz Dionísio, Joana, et al.
Publicado: (2021)

COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab
por: Cross, Anne H., et al.
Publicado: (2022)

Willingness to accept COVID-19 vaccination among people living with HIV in a high HIV prevalence community
por: Govere-Hwenje, Sabina, et al.
Publicado: (2022)

Willingness to accept COVID-19 vaccination among people living with HIV in a high HIV prevalence community
por: Govere-Hwenje, Sabina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4pgua0h7rpqgprn4n63h71plui